(OE) BIOC-046: A Longitudinal Therapy Response Monitoring Study in Subjects with Leptomeningeal Metastases using CNSide (CSF Tumor Cells) Compared to Standard of Care (CSF Cytology, Clinical Evaluation, and Imaging).

Project: Research project

Project Details

StatusActive
Effective start/end date4/11/23 → 4/11/26

Funding

  • ICON Clinical Research, LLC (BIOC-046)
  • Biocept, Inc. (BIOC-046)